阿拉丁上海 分子式 C138H216N42O45
diabetes. Dipeptidyl peptidase-4 (DPP-4) inhibitors have been demonstrated to improve glycemic control, in particular
α and PPARγ. Aleglitazar is being developed for the treatment of type II diabetes; It is currently in phase III clinical
Fagomine (D-Fagomine) is useful for diabetes
GW-1100 is G protein-coupled receptor GPR40. In treatment of diabetes
dipeptidyl peptidase-4 (DPP-4) inhibitor that is being developed for the treatment of type 2 diabetes (T2D). Two Phase II
treatment for type 2 diabetes that targets G protein-coupled receptor 119 (GPR119), a receptor that interacts
progression of diabetes
for the management of hyperglycemia in diabetes Anticancer agents Integrase strand-transfer inhibitors (INSTIs
agents. The enzyme is highly specific for uric acid. Mice deficient in uricase develop uric acid nephropathy and diabetes
关于批准发布《电动自行车用锂离子蓄电池安全技术规范》强制性国家标准的公告
被印度“围剿”的中国CAR-T:不仅是药企不“争气”
关于筹备中国检验检测学会青年科技工作者委员会委员的通知
莱伯泰科2023年营收稳步增长,加大研发布局全产业链
404亿助力地方高校发展,中西部高校迎变革
国家药监局关于印发药品抽检探索性研究原则及程序的通知
20余所高校,获批国自然博士生项目(附名单)
中纪委发文:紧盯「器械采购」关键岗位
首届分析科学与仪器大会盛大启幕:汇聚百余位院士专家
2023年度药品审评报告
咨询热线: 010-84839035
联系邮箱: sales@antpedia.net